The heart in muscular dystrophy

Pediatric Annals

Volumn 34, Issue 7, 2005, Pages 531-535

  Markham, Larry W ^a   Spicer, Robert L ^a   Cripe, Linda H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANAMNESIS; BECKER MUSCULAR DYSTROPHY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; DUCHENNE MUSCULAR DYSTROPHY; FATIGUE; GENE MUTATION; HEART DISEASE; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; SINUS TACHYCARDIA; SLEEP DEPRIVATION; SUDDEN DEATH; WEIGHT GAIN; WEIGHT REDUCTION; X CHROMOSOME LINKED DISORDER;

EID: 23044493089     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20050701-10     Document Type: Review

References (27)

1. Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol. 2003;16(5):577-583.
2. Leth A, Wulff K. Myocardiopathy in Duchenne progressive muscular dystrophy. Acta Paediatr Scand. 1976;65(1):28-32.
3. Perloff JK, de Leon AC Jr, O'Doherty D. The cardiomyopathy of progressive muscular dystrophy. Circulation. 1966;33(4):625-648.
4. Eagle M, Baudouin S, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12(10):926-929.
5. Bhakta D, Groh W. Cardiac function tests in neuromuscular diseases. Neurol Clin. 2004;22(3):591-617, vi.
6. Swedberg K, Eneroth P, Kjekshus, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82(5):1730-1736.
7. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 1996;94(9):2285-2296.
8. Ishikawa Y, Minami R, Bach JR. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J. 1999;137(5):895-902.
9. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325(5):293-302.
10. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001;138(4):505-511.
11. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol. 1999;83(2A):1A-38A.
12. Duboc D, Meune C, Lerebours G, et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol. 2005;45(6):855-857.
13. Hunt SA, Baker DW, Chin MH, et al. ACC/ AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant. 2002;21(2):189-203.
14. Finsterer J, Bittner RE, Grimm M. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement. Neuromuscul Disord. 1999;9(8):598-600.
15. Davies JE, Winokur TS, Aaron MF, et al. Cardiomyopathy in a carrier of Duchenne's muscular dystrophy. J Heart Lung Transplant. 2001;20(7):781-784.
16. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13.
17. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919-928.
18. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve. 2000;23(10):1456-1471.
19. Manning GW, Cropp CJ. Electrocardiogram in progressive muscular dystrophy. Br Heart J. 1958;20(3):416-420.
20. Schott J, Jacobi M, Wald MA. Electrocardiographic patterns in the differential diagnosis of progressive muscular dystrophy. Am J Med Sci. 1955;229(5):517-524.
21. Perloff JK, Roberts WC, de Leon AC Jr, O'Doherty D. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med. 1967;42(2):179-188.
22. Nigro G, Comi L, Politano L, Bain R. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990;26(3):271-277.
23. Bushby K. The limb-girdle muscular dystrophies - multiple genes, multiple mechanisms. Hum Mol Gen. 1999;8(10):1875-1882.
24. Bushby K, Muntoni F, Bourke J. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord. 2003;13(2):166-172.
25. van der Kooi AJ, de Voogt WG, Barth PG, et al. The heart in limb girdle muscular dystrophy. Heart. 1998;79(1):73-77.
26. Mathews KD. Muscular dystrophy overview: genetics and diagnosis. Neurol Clin. 2003;21(4):795-816.
27. Voit T. Congenital muscular dystrophies: 1997 update. Brain Dev. 1998;20(2):65-74.